Type to search

Marine Science


Inter Pharma and Thai Union create new joint venture. Inter Pharma Public Company Limited and Thai Union Ingredients, a subsidiary of global seafood giant Thai Union Group PCL., have announced their joint investment in Interpharma-ZEAvita Co., Ltd., with a registered capital of 20 million baht.

Inter Pharma will hold 50.99995% of the shares, with Thai Union Ingredients owning 49% and Trinnawat Thanitnithiphan 0.00005%. The newly established company will focus on research and development as well as the manufacturing and distribution of healthy products, responding to consumer trends that focus more on wellbeing.

“This joint venture combines the strength of the two companies to further our business growth. This investment will be another key factor in InterPharma’s middle-term growth strategies. We expect to see at least 25% sale growth to reach 2 billion baht by 2024,” said Dr Trinnawat Thanitnithiphan, CEO of Inter Pharma.

For Thiraphong Chansiri, CEO at Thai Union, the investment supports Thai Union’s plan to expand from its core seafood business to healthy products driven by innovation. “As consumers are increasingly focused on health and wellbeing, Thai Union Thailand is committed to a strategy of healthy living and healthy oceans as this is clearly where future growth lies.”

Inter Pharma is committed to improving and delivering health care with innovative products. The company focuses on 4 categories: Wellness and Anti-Aging Products, Aesthetic Innovation Products, Companion Animal Health Products and Livestock Products.